A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
To evaluate the pharmacokinetic (PK) profiles of ceftaroline and avibactam in adults with augmented renal clearance (ARC).
To evaluate the single-dose pharmacokinetic (PK) profiles of ceftaroline and avibactam following intravenous (IV) administration of ceftaroline fosamil/avibactam ("CXL") in adults with augmented renal clearance (ARC).
Inclusion Criteria:
Male or female adults ≥ 18 and ≤ 55 years old
Augmented renal clearance, defined as:
Hospitalized and diagnosed with SIRS, defined by at least 2 of the following:
Requires indwelling urinary bladder catheter per standard of care (through the end of the 8-hour urine collection)
Exclusion Criteria: